

Page contents:
Diabetes prevention
The rising incidence of type 2 diabetes is closely associated with the epidemic of overweight and obesity. In the six years between 1997 and 2003, the number of new cases of type 2 diabetes in the United Kingdom has risen by 74%, demonstrating a more rapid acceleration than anticipated1. This magnitude of acceleration in the incidence of type 2 diabetes in the UK is also supported by another study which reports and annual rate of increase in Type 2 diabetes incidence of 11.8% occurring between 2003 and 20052.
"Pre-diabetes"
A significant driver of the Cut the Waist concept was to raise awareness of evidence from a number of major studies which clearly demonstrate that type 2 diabetes can be prevented in over half of the people known to be at high risk of developing this condition.
Impaired Fasting Glycaemia
Fasting venous glucose value from 6.1mmol/l to 6.9mmol/l
Impaired Glucose Tolerance
Two hours following an oral glucose challenge of 75g glucose, venous glucose value of 7.8mmol/l up to 11mmol/l
Many people are identified with impaired glucose control but do not reach the World Health Organisation criteria for a diagnosis of type 2 diabetes. "Pre-diabetes" or "non-diabetic hyperglycaemia" are terms often used to describe impaired glucose control which does not reach the diagnostic criteria for frank type 2 diabetes. People with pre-diabetes are at high risk of progression to type 2 diabetes over time.
Pre-diabetic conditions include either an impairment of glucose control identified in the fasting state [Impaired Fasting Glycaemia /IFG] or impairment of glucose control identified following a glucose challenge [Impaired Glucose Tolerance/IGT]. The conditions can occur in isolation or as a mixed picture of both IFG and IGT.
Type 2 diabetes
A single fasting venous glucose of ≥7mmol/l in the presence of symptoms suggesting type 2 diabetes.
In the absence of symptoms, diagnosis requires confirmation of a fasting venous glucose of ≥7mmol/l
A single random venous glucose of ≥11.1mmol/l in the presence of symptoms suggesting type 2 diabetes.
In the absence of symptoms, diagnosis requires confirmation of a random venous glucose of ≥11.1mmol/l or fasting venous glucose of ≥7mmol/l
Lifestyle approaches have proved to be effective in slowing the progression of pre-diabetes to type 2 diabetes. The major diabetes prevention studies listed below demonstrate that type 2 diabetes is a preventable or at least postponable condition in the majority of people who have pre-diabetes.
The Diabetes Prevention Programme (DPP) involved over three thousand participants with pre-diabetes. The DPP reported a 58% reduction in progression to type 2 diabetes via lifestyle changes associated with a loss of 6% of initial body weight and maintenance of 3.5% weight loss at 3 years3.
Similarly in the Finnish Diabetes Prevention Study, a dietary, exercise and behavioural change programme achieved a weight loss in the region of 4% that was maintained over 4 years. This lifestyle intervention reduced the incidence of progression to type 2 diabetes in subjects with impaired glucose tolerance IGT by 58%4. Furthermore, although the intervention ceased at four years, the subjects who received the lifestyle advice continued to be protected against developing type 2 diabetes when followed up 8 years after the start of the programme5. The Finnish Diabetes Prevention Study data clearly demonstrates that lifestyle intervention can result in long-lasting diabetes-prevention benefits.
The above studies provide evidence that small reductions in body weight in the region of 4% protect those at high risk from progressing to type 2 diabetes. To emphasize the impact of small changes in body weight, one study demonstrated a weight loss of just 1kg reduced the progression of patients with pre-diabetes (impaired glucose tolerance) to frank type 2 diabetes by 20% over a three year period of follow up6.
Acknowledgements
'Diabetes and obesity: a joined up approach to management' artwork reproduced with permission ©SB Communications Group 2009
References
1. Masso Gonzalez EL, Johansson S, Wallander M-A, Garcia Rodriguez LA. Trends in the Prevalence and Incidence of diabetes in the UK: 1996-2005. J Epidemiol Community Health 2009; 0: 1-5. doi:10.1136/jech.2008.080382 (accessed 7.09.2009)
2. Thomas MC, Hardoon SL, Papacosta AO, Morris RW, Wannamethee SG, Sloggett A, Whincup PH. Evidence of an accelerating increase in the prevalence of diagnosed Type 2 diabetes in British men, 1978-2005. Diabetic Medicine 2009; 26: 766-772
3. Diabetes Prevention Programme Research Group: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346: 393-403
4. Diabetes Prevention Program Research G. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346: 393-403
5. Lindstrom J, ILANNE-Parikka P, Peltonen M, Anoula S, Eriksson J, Hemio K. Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow up of the Finnish Diabetes Prevention Study. Lancet 2006; 368: 1763-1679
6. Rasmussen SS, Glumer C, Sandbaek A, Lauritzen T, Borch-Johnsen K. Determinants of progression from impaired fasting glucose and impaired glucose tolerance to diabetes in a high-risk screened population: 3yr follow up in the ADDITION study, Denmark. Diabetologica 2008; 51: 249-257

